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Abstract Recent studies have demonstrated that ceramide plays
an important role as a second messenger in many kinds of cells.
However, it is not known whether apoptosis of and bone
resorption by mature osteoclasts are mediated via sphingomye-
linase (SMase) and ceramide. Thus, we examined the possible
involvement of SMase and ceramide in the induction of apoptosis
in and bone resorption by rabbit mature osteoclasts. SMase and
C2-ceramide inhibited strongly F-actin ring formation of and
bone resorption by the osteoclasts. However, the osteoclast
apoptosis was not induced by C2-ceramide. The ceramide
inhibition of the bone resorption was suppressed by DL-threo-
dihydrosphingosine, an inhibitor of sphingosine kinase. In
addition, we observed that sphingosine-1-phosphate is able to
inhibit bone resorption by the osteoclasts. These results suggest
an important role of the sphingomyelin pathway in bone
resorption by rabbit mature osteoclasts.
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1. Introduction
Many recent studies [1^9] have demonstrated that the
sphingomyelin pathway is a new transducing pathway medi-
ating the action of several biological and physical stimulators.
This signal pathway is triggered by activation of a neutral
sphingomyelinase (SMase) that hydrolyzes membrane sphin-
gomyelin to ceramide. Recently, also, it has been shown that
ceramide acts as a second messenger via activation of a cer-
amide-activated protein kinase. On the other hand, interesting
studies [10^16] have shown that membrane-permeable cer-
amide is able to mimic the biological action of several
stimulators such as tumor necrosis factor K (TNF-K), inter-
leukin-1 (IL-1), lipid A, and so on.
Osteoclasts are multinucleate cells that dissolve bone matrix
and minerals and play a central role in bone remodeling. The
bone-resorbing activity of osteoclasts is closely regulated by
systemic and local factors such as retinoic acid, vitamin D3,
prostaglandins, transforming growth factor L (TGF-L), TNF-
K and interleukin 1 [17^23]. In addition, the cell activity is
also controlled by mechanical stress. Since these observations
suggested the possibility that ceramide may be involved in the
activity of osteoclasts, it is of interest to examine whether
ceramide acts as a potent regulator of bone resorption by
osteoclasts. So, in the present study, we investigated the e¡ect
of SMase and ceramide on the bone-resorbing activity of rab-
bit mature osteoclasts. We show here that ceramide inhibits
this activity via disruption of the ringed structure of F-actin
(actin ring) that is contained in the podosomes of their bone-
resorbing cells.
2. Materials and methods
2.1. Reagents
Sphingomyelinase, DL-threo-dihydrosphingosine (DL-dihydros-
phin.), and sphingosine-1-phosphate (Sph.-1-phos.) were purchased
from Sigma Chem. Co. (St. Louis, MO, USA). C2-ceramide was
from Molecular Probes, Inc. (Eugene, OR, USA).
2.2. Osteoclast isolation and bone-resorbing activity on dentine slice
Osteoclasts were obtained from minced long bones of 10-day-old
Japanese white rabbits (Saitama Experimental Animal Supply Co.,
Saitama, Japan) according to the modi¢ed method as described orig-
inally by Hattersley et al. [24]. The cell suspension was separated on a
Percoll density gradient at 1.07 g/ml. The upper band, containing
mature osteoclasts, was recovered and washed three times with K-
MEM. This cell population was plated on dentine slices in each
well of Falcon 24-well £at multiplates and incubated in 10% fetal
calf serum (FCS)-containing K-MEM. After 1 h of incubation, the
dentine slices were washed to remove tissues debris and non-adherent
cells, and then the slices bearing adherent osteoclastic cells were in-
cubated in 10% FCS-containing K-MEM supplemented with or with-
out test samples. After 16 h of incubation, the pit number was
counted as the bone-resorbing activity of mature osteoclasts. The
results are expressed as the mean þ S.D. of quadruplicate cultures.
2.3. Agarose gel electrophoresis for DNA fragmentation
Osteoclast DNA fragmentation was assessed as described previ-
ously [25]. Brie£y, the osteoclasts were treated or not with C2-ceram-
ide and then lysed by incubation in digestion bu¡er. The DNA was
extracted with phenol/chloroform, precipitated with 0.5 M NaCl
and ethanol, and electrophoresed on 3% agarose gel containing ethi-
dium bromide. The DNA fragments were then visualized under UV
light.
2.4. Podosome formation in puri¢ed osteoclasts
Puri¢ed rabbit osteoclasts were prepared from cell suspensions of
long bones according to the modi¢ed method of Tezuka et al. Brie£y,
the TRAP-positive bone cells (4U102 cells) were inoculated into each
well of a LabTek chamber (Nunc, Naperville, IL). After 3 h of in-
cubation, the cell monolayer was treated with 0.001% pronase E to
remove the stromal cells. The remaining puri¢ed osteoclasts were
cultured for selected times in 10% FCS-containing K-MEM supple-
mented or not with test samples. Thereafter, the osteoclasts were ¢xed
with 3% formaldehyde in phosphate-bu¡ered saline (PBS) for 10 min,
and then washed with PBS. F-actin was stained for 30 min at room
temperature with 0.3 mM £uorescence-conjugated phalloidin (Sigma).
Distribution of F-actin was detected under a £uorescence microscope
(Olympus BX60, Tokyo, Japan).
3. Results and discussion
3.1. SMase and ceramide inhibit F-actin ring formation by
rabbit mature osteoclastic cells
Since it is well known that formation of F-actin rings in
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mature osteoclasts is essential for their bone-resorbing activ-
ity, we ¢rst examined the e¡ect of SMase and C2-ceramide on
F-actin ring formation by the mature osteoclasts. As shown in
Fig. 1, the F-actin ring formation observed in control osteo-
clasts was clearly prevented by SMase or ceramide treatment.
These observations suggested to us the possibility that SMase
and ceramide may act as inhibitors of osteoclastic bone re-
sorption, because F-actin ring formation plays an important
role in osteoclastic bone resorption.
3.2. SMase and ceramide inhibit bone resorption of rabbit
mature osteoclasts
We next examined the possibility that SMase and ceramide
may inhibit bone resorption by rabbit mature osteoclasts. Fig.
2A,B shows the results. SMase and C2-ceramide inhibited
their bone-resorbing activity in a dose-dependent manner. In
addition, we also examined the kinetics of the inhibitory e¡ect
of ceramide on bone resorption. Signi¢cant inhibition by cer-
amide was observed at 12 h after the initiation of the treat-
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Fig. 1. SMase and C2-ceramide inhibit formation of F-actin ring in rabbit mature osteoclasts. Isolated osteoclasts prepared as described in Sec-
tion 2, i.e. TRAP-positive bone cells (4U102 cells), were inoculated into each well of a LabTek chamber, and then treated or not with SMase
(10 WM) or C2-ceramide (5 WM). After 3 h of incubation, the cells were ¢xed with 3% formaldehyde, and then washed. F-actin was stained for
30 min at room temperature with 0.3 mM £uorescence-conjugated phalloidin. Distribution of F-actin was detected under a £uorescence micro-
scope. Three identical experiments independently performed gave similar results.
Fig. 2. Inhibitory e¡ect of SMase and C2-ceramide on osteoclast-mediated bone resorption. TRAP-positive cells (1U103 cells) in a femoral
bone cell suspension were inoculated onto each of several dentine slices, and the slices were rinsed 1 h later to remove the non-adherent stromal
cells. Then the cells were treated or not with SMase (A) or C2-ceramide (B) at the indicated doses. After 18 h incubation, the resorption pit
number was counted. The results are expressed as the mean þ S.D. of quadruplicate cultures. Three identical experiments independently per-
formed gave similar results.
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ment, and thereafter the inhibitory activity of C2-ceramide
was retained at least up to 24 h (Fig. 3). To ensure that the
inhibitory e¡ects were not the result of its cytotoxic action
toward the cells, we incubated mature osteoclasts on dentine
slice for 18 h with or without C2-ceramide (5 WM) and then
counted the cell number reacting with TRAP, a marker en-
zyme of osteoclasts, in the cells. Although the data are not
shown, the number of TRAP-positive cells was not a¡ected by
the treatment with ceramide. In addition, to know whether the
ceramide inhibition resulted from its stimulation of the osteo-
clast apoptosis, we explored the e¡ect of C2-ceramide on this
process. Fig. 4 shows that C2-ceramide did not induce any
DNA fragmentation, a marker of apoptosis, in the osteo-
clasts. These observations strongly indicate that ceramide
acts as second messenger to inhibit mature osteoclastic func-
tion.
3.3. Sph.-1-phos. mediates ceramide inhibition of bone
resorption by mature osteoclastic cells
Since it is known that ceramide induces several biological
activities via sph.-1-phos., we next examined the possible in-
volvement of this glycolipid in the ceramide-induced inhibi-
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Fig. 3. Kinetics of C2-ceramide inhibition of osteoclast-mediated
bone resorption. TRAP-positive cells (1U103 cells) in a femoral
bone cell suspension were inoculated onto each of several dentine
slices, and the slices were rinsed 1 h later to remove the non-adher-
ent stromal cells. Then the cells were treated or not with C2-ceram-
ide at 5 WM. After the selected times, the resorption pit number was
counted. The results are expressed as the mean þ S.D. of quadrupli-
cate cultures. Three identical experiments independently performed
gave similar results.
Fig. 4. C2-ceramide does not induce apoptosis of rabbit mature os-
teoclasts. TRAP-positive cells (1U104 cells) in a femoral bone cell
suspension were inoculated into each well of a Lab-Tek chamber,
and then isolated osteoclasts prepared as described in Section 2
were treated (lane 3) or not (lane 2) with C2-ceramide at 5 WM.
The cells were lysed in digestion bu¡er 12 h later. Then their ge-
nomic DNA was extracted and subjected to agarose gel electropho-
resis. PX174 RF DNA/HaeIII fragments were used as molecular
weight markers (lane 1).
Fig. 5. DL-dihydrosphin. abolishes C2-ceramide inhibition of osteo-
clast-mediated bone resorption. TRAP-positive cells (1U103 cells) in
a femoral bone cell suspension were inoculated onto each of several
dentine slices and slices were rinsed 1 h later to remove the non-ad-
herent stromal cells. Then the cells were pretreated or not with DL-
dihydrosphin. at the indicated doses. C2-ceramide was added or not
to the cell cultures 1 h later. After 18 h incubation, the resorption
pit number was counted. The results are expressed as the
mean þ S.D. of quadruplicate cultures. Two identical experiments in-
dependently performed gave similar results.
Fig. 6. Sph.-1-phos. inhibits osteoclast-mediated bone resorption.
TRAP-positive cells (1U103 cells) in a femoral bone cell suspension
were inoculated onto each of several dentine slices, and the slices
were rinsed 1 h later to remove the non-adherent stromal cells.
Then the cells were treated or not with sph.-1-phos. at the indicated
doses. After 18 h incubation, the resorption pit number was
counted. The results are expressed as the mean þ S.D. of quadrupli-
cate cultures. Two identical experiments independently performed
gave similar results.
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tion of bone resorption. As shown in Fig. 5, ceramide inhib-
ition of the osteoclastic bone resorption was eliminated in a
dose-dependent fashion by DL-dihydrosphin., an inhibitor of
sphingosine kinase and hence of sph.-1-phos. production. As
these results suggested involvement of sph.-1-phos. in ceram-
ide inhibition of the osteoclastic bone resorption, ¢nally we
examined whether sph.-1-phos. itself is able to inhibit bone
resorption of the osteoclastic cells. Fig. 6 shows that this is
indeed the case.
It is well known that F-actin ring formation is essential for
ru¥ed border formation in and also bone resorption by os-
teoclasts. Interestingly, it has been shown that the ru¥ed bor-
der was not detected in osteoclasts of c-src knockout mice,
which manifest a typical osteopetrosis [26]. As Boyce et al.
[27] showed previously, we also observed that herbimycin A, a
potent inhibitor of c-src tyrosine kinase, dramatically inhib-
ited bone resorption by rabbit osteoclasts (unpublished data).
These observations suggest that the oncogene tyrosine kinase
is intimately involved in the ru¥ed border of and bone re-
sorption by the osteoclasts. The present study showed that
SMase and C2-ceramide inhibited bone resorption by rabbit
osteoclasts through suppression of F-actin ring formation. It
is of interest to elucidate which signal pathway of the ceram-
ide, a second messenger, mediates the inhibitory action. Since
sph.-1-phos. inhibited the bone resorption by the cells, we
propose a signal pathway of ceramide inhibitory action of
the bone resorption via sph.-1-phos., because the ceramide
inhibition was abolished by treatment with DL-dihydrosphin.
Since we now do not know the mechanism of SMase- and C2-
ceramide-induced inhibition of F-actin ring formation in rab-
bit mature osteoclasts, further studies are required to elucidate
this inhibitory mechanism.
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